LVTX
Price:
$1.74
Market Cap:
$45.77M
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a robust anti-tumor immune response and ultimately enhance outcomes for individuals battling cancer. Key compounds in its clinical pipeline include LAVA-051, currently undergoing Phase 1/2a trials for various hematologic malignancies such as chronic lymphocytic leukemia, multiple myeloma, and acute myelo...[Read more]
Industry
Biotechnology
IPO Date
2021-03-26
Stock Exchange
NASDAQ
Ticker
LVTX
According to LAVA Therapeutics N.V.’s latest financial reports and current stock price. The company's current ROE is -108.07%. This represents a change of 238.24% compared to the average of -31.95% of the last 4 quarters.
The mean historical ROE of LAVA Therapeutics N.V. over the last ten years is -103.32%. The current -108.07% ROE has changed 4.60% with respect to the historical average. Over the past ten years (40 quarters), LVTX's ROE was at its highest in in the June 2020 quarter at 231.21%. The ROE was at its lowest in in the June 2019 quarter at -167.97%.
Average
-103.32%
Median
-86.17%
Minimum
-208.99%
Maximum
-35.78%
Discovering the peaks and valleys of LAVA Therapeutics N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.62%
Maximum Annual ROE = -35.78%
Minimum Annual Increase = -82.88%
Minimum Annual ROE = -208.99%
| Year | ROE | Change |
|---|---|---|
| 2024 | -90.52% | 10.64% |
| 2023 | -81.81% | 120.62% |
| 2022 | -37.08% | 3.64% |
| 2021 | -35.78% | -82.88% |
| 2020 | -208.99% | 26.08% |
The current ROE of LAVA Therapeutics N.V. (LVTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-69.81%
5-year avg
-90.84%
10-year avg
-103.32%
LAVA Therapeutics N.V.’s ROE is less than CalciMedica, Inc. (4.09%), less than Lantern Pharma Inc. (-0.97%), greater than Actinium Pharmaceuticals, Inc. (-218.67%), greater than Tvardi Therapeutics, Inc. (-64.17%), greater than Xilio Therapeutics, Inc. (-117.24%), greater than PDS Biotechnology Corporation (-346.03%), less than Celularity Inc. (411.46%), greater than Reviva Pharmaceuticals Holdings, Inc. (-220.39%), greater than Tempest Therapeutics, Inc. (-729.89%), greater than Elutia Inc. (-560.64%),
| Company | ROE | Market cap |
|---|---|---|
| 4.09% | $13.70M | |
| -0.97% | $49.50M | |
| -218.67% | $31.69M | |
| -64.17% | $24.77M | |
| -117.24% | $54.64M | |
| -346.03% | $58.61M | |
| 411.46% | $17.15M | |
| -220.39% | $2.33M | |
| -729.89% | $5.60M | |
| -560.64% | $42.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Therapeutics N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LAVA Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is LAVA Therapeutics N.V.'s ROE?
How is the ROE calculated for LAVA Therapeutics N.V. (LVTX)?
What is the highest ROE for LAVA Therapeutics N.V. (LVTX)?
What is the 3-year average ROE for LAVA Therapeutics N.V. (LVTX)?
What is the 5-year average ROE for LAVA Therapeutics N.V. (LVTX)?
How does the current ROE for LAVA Therapeutics N.V. (LVTX) compare to its historical average?